StockData
Acurx Pharmaceuticals, Inc. logo

Acurx Pharmaceuticals, Inc. (ACXP) stock

ACXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.99+0.05 (+5.88%)

Close on Nov 17, 2026Market cap $5.22MP/E –Yield –

Acurx Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Acurx Pharmaceuticals's market cap was $4.82M on Nov 11, 2026, against $6.99M a year earlier. Over the last 5 years it ranged from $3.52M to $62.21M, with a median of $30.39M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$4.82M+7.6%
2025Dec 31, 2025$4.48M-65.6%
2024Dec 31, 2024$13.02M-70.8%
2023Dec 29, 2023$44.53M+9.0%
2022Dec 30, 2022$40.85M-6.7%
2021Dec 31, 2021$43.76M–

More Acurx Pharmaceuticals figures

See a number that looks wrong?